Transfusion-transmitted cytomegalovirus (CMV) infections in a murine model: characterization of CMV-infected donor mice
- 1 June 2006
- journal article
- Published by Wiley in Transfusion
- Vol. 46 (6) , 889-895
- https://doi.org/10.1111/j.1537-2995.2006.00820.x
Abstract
Donor and recipient mechanisms that modulate the incidence and severity of transfusion-transmitted cytomegalovirus (TT-CMV) are unclear. The kinetics of murine CMV (MCMV) infection in the peripheral blood of donor mice were investigated to determine the utility of this model for studying TT-CMV. BALB/cByJ mice, experimentally infected with Smith strain MCMV, were killed at serial time points up to 28 days after infection. Peritoneal exudate cells (PECs), peripheral blood white blood cells (WBCs), plasma, and marrow were tested for MCMV DNA with quantitative polymerase chain reaction (PCR), replication-competent virus with quantitative culture, and transcription of viral genes with reverse transcription (RT)-PCR targeted at the immediate-early 1 (ie1) gene. PECs, macrophages infected by MCMV shortly after intraperitoneal inoculation, demonstrated high mean levels of MCMV DNA (10(5)-10(7) genome equivalents [geqs]/10(5) PECs), virus production (10(1)-10(4) infectious virions/10(5) PECs), and ie1 gene transcription, demonstrating productive infection. In contrast, while MCMV loads averaged 10(4) to 10(6) geqs per 10(5) peripheral WBCs, all WBC samples were uniformly negative for MCMV ie1 expression by RT-PCR and for culturable virus, consistent with latent MCMV infection. Plasma and marrow showed lower viral loads than WBCs and PECs and were all negative by culture and RT-PCR analysis. Following experimental MCMV infection, murine peripheral blood WBCs appear to be latently infected with virus (MCMV DNA-positive; MCMV RNA-negative; MCMV culture-negative), similar to the latently infected human monocytes in peripheral blood of CMV-seropositive donors. These donor kinetics suggest that the experimental MCMV system can be used to effectively model the mechanisms of TT-CMV infections in humans.Keywords
This publication has 24 references indexed in Scilit:
- Photochemical treatment of platelet concentrates with amotosalen hydrochloride and ultraviolet A light inactivates free and latent cytomegalovirus in a murine transfusion modelTransfusion, 2004
- Latency and Reactivation of Human CytomegalovirusJournal of Infection, 2002
- Methods for the reduction of transfusion‐transmitted cytomegalovirus infection: filtration versus the use of seronegative donor unitsTransfusion, 1994
- Indications for the Use of Cytomegalovirus-Seronegative Blood ProductsTransfusion Medicine Reviews, 1991
- The risk of cytomegalovirus infection in solid organ and bone marrow transplant recipients: transfusion of blood productsTransfusion, 1990
- Cytomegalovirus Immune Globulin and Seronegative Blood Products to Prevent Primary Cytomegalovirus Infection after Marrow TransplantationNew England Journal of Medicine, 1986
- Cytomegalovirus Infection in the Normal HostMedicine, 1985
- Prevention of transfusion-acquired cytomegalovirus infections in newborn infantsThe Journal of Pediatrics, 1981
- Transmission and Activation of Cytomegalovirus with Blood Transfusion: A Mouse ModelThe Journal of Infectious Diseases, 1977
- Infectious-mononucleosis-like Disease with Negative Heterophil Agglutination Test. Clinical Features in Relation to Epstein-Barr Virus and Cytomegalovirus AntibodiesThe Journal of Infectious Diseases, 1970